Isobavachin inhibits osteoclastogenesis in inflammatory osteolysis loss by modulating the ROS-mediated Nrf2/HO-1 signaling pathway.
Liang Liao, Yunde Xu, Jindeng Liao, Xiaohui Liu
The Journal of pharmacy and pharmacology · 2026 · DOI 10.1093/jpp/rgag049